Tarsus Pharmaceuticals (TARS) director gains 1,383 shares from RSU vesting

Q: What did Tarsus (TARS) director David Pyott report in this Form 4?

David E. I. Pyott reported the settlement of 1,383 Restricted Stock Units into 1,383 shares of Tarsus common stock. This is a compensation-related equity grant , not an open‑market stock purchase or sale.

Q: Were any Tarsus (TARS) shares bought or sold on the open market in this filing?

No. The filing shows no open‑market purchases or sales . Instead, vested RSUs converted into 1,383 shares of common stock at a stated price of $0.00 per share , reflecting a non‑cash equity award.

Q: How many Tarsus (TARS) shares does David Pyott hold after these transactions?

After the RSU settlement, David Pyott holds 1,383 common shares directly and 7,991 common shares indirectly through the David E.I. Pyott Trust , as disclosed in the Form 4 ownership tables.

Q: What are Restricted Stock Units (RSUs) in the Tarsus (TARS) Form 4?

In this filing, Restricted Stock Units are equity awards that vest over time and then convert into common stock. Each RSU represents a contingent right to receive one Tarsus share once vesting conditions, including continuous service, are satisfied.

Q: When did the Tarsus (TARS) RSUs reported by David Pyott vest?

The RSUs reported by David Pyott vested in full on April 24, 2026 , subject to his continuous service . On that vesting date, 1,383 RSUs were settled into an equal number of Tarsus common shares.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Tarsus Pharmaceuticals, Inc. director David E. I. Pyott acquired common stock through equity compensation rather than open‑market trading. On April 24, 2026, 1,383 shares of common stock were issued upon settlement of vested Restricted Stock Units (RSUs), with each RSU converting into one share.

The RSUs vested in full on that date, subject to his continuous service. Following these transactions, he holds 1,383 shares directly and 7,991 shares indirectly through the David E.I. Pyott Trust.

Insider Trade Summary

1,383 shares exercised/converted

Mixed 3 txns

Insider PYOTT DAVID E I

Role null

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	1,383	$0.00	--
Exercise	Common Stock	1,383	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock — 1,383 shares (Direct, null); Common Stock — 7,991 shares (Indirect, By the David E.I. Pyott Trust)

Footnotes (1)

The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vested in full on April 24, 2026, subject to the Reporting Person's continuous service.

Key Figures

RSUs settled: 1,383 units Shares acquired from RSUs: 1,383 shares Indirect holdings after transaction: 7,991 shares +2 more

5 metrics

RSUs settled 1,383 units Converted into common stock on April 24, 2026

Shares acquired from RSUs 1,383 shares Common stock issued at $0.00 per share on settlement

Indirect holdings after transaction 7,991 shares Common stock held by the David E.I. Pyott Trust

Direct holdings after transaction 1,383 shares Common stock held directly by David E. I. Pyott

Derivative exercises 1 transaction, 1,383 shares Exercise/conversion of RSUs into common stock

Key Terms

Restricted Stock Units, derivative exercise/conversion, contingent right, indirect ownership

4 terms

Restricted Stock Units financial

"The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs")."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

derivative exercise/conversion financial

"transaction_action": "derivative exercise/conversion""

contingent right financial

"Each RSU represents a contingent right to receive one share of the Company's common stock."

indirect ownership financial

"ownership_type": "indirect""

Form 4 Insider Transactions: What Each Field Means →

04/28/2026 - 04:23 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PYOTT DAVID E I

(Last)

(First)

(Middle)

C/O TARSUS PHARMACEUTICALS

15440 LAGUNA CANYON ROAD, SUITE 160

(Street)

IRVINE

CALIFORNIA

92618

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Tarsus Pharmaceuticals, Inc. [ TARS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/24/2026		M⁽¹⁾		1,383	A	⁽¹⁾	1,383	D
Common Stock								7,991	I	By the David E.I. Pyott Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽²⁾	04/24/2026		M			1,383	⁽³⁾	⁽³⁾	Common Stock	1,383	$0	0	D

Explanation of Responses:

1. The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

2. Each RSU represents a contingent right to receive one share of the Company's common stock.

3. The RSUs vested in full on April 24, 2026, subject to the Reporting Person's continuous service.

Remarks:

	/s/ Scott Sieckert, Attorney-in-Fact	04/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Tarsus (TARS) director David Pyott report in this Form 4?

David E. I. Pyott reported the settlement of 1,383 Restricted Stock Units into 1,383 shares of Tarsus common stock. This is a compensation-related equity grant, not an open‑market stock purchase or sale.

Were any Tarsus (TARS) shares bought or sold on the open market in this filing?

No. The filing shows no open‑market purchases or sales. Instead, vested RSUs converted into 1,383 shares of common stock at a stated price of $0.00 per share, reflecting a non‑cash equity award.

How many Tarsus (TARS) shares does David Pyott hold after these transactions?

After the RSU settlement, David Pyott holds 1,383 common shares directly and 7,991 common shares indirectly through the David E.I. Pyott Trust, as disclosed in the Form 4 ownership tables.

What are Restricted Stock Units (RSUs) in the Tarsus (TARS) Form 4?

In this filing, Restricted Stock Units are equity awards that vest over time and then convert into common stock. Each RSU represents a contingent right to receive one Tarsus share once vesting conditions, including continuous service, are satisfied.

When did the Tarsus (TARS) RSUs reported by David Pyott vest?

The RSUs reported by David Pyott vested in full on April 24, 2026, subject to his continuous service. On that vesting date, 1,383 RSUs were settled into an equal number of Tarsus common shares.